On proving disease causation, research bias and misuse of science in the case of the tobacco industry

Event Date: 
Tuesday, 18 October, 2016 - 13:00
Location: 
IBMI
Lecturer: 
Luka Šolmajer, M. Sc. Pharm., CRO - CRS d.o.o.

In the year 1953 numerous medical studies as well as internal tobacco industry studies showed that tobacco smoke causes cancer. That is why the tobacco industry began an enormous campaign to deny the effects of smoking. Science that they financed was not usually directly flawed but rarely had anything to do with the effect of smoking on health. If the dangers of smoking were shown, they stopped the project or denied the rights of publishing the research. They have financed researchers from various fields to testify on behalf of the tobacco industry in courts, in the American congress and publically supported them without revealing their financers. A known biostatistician testified before the American congress that smoking and lung cancer were not statistically related. Another professor of mathematics received around 10 mio. USD to ridicule the number of deaths due to smoking. Another author of the history of lung cancer wrote that lung cancer was not really increasing, that this was just a consequence of improved diagnostics. He did not reveal that the tobacco industry was paying him. Several psychologists and psychiatrists testified that smoking is a habit and not an addiction; they denied the effects of nicotine and stressed the genetic factors. In 2016 the Economic Faculty in Ljubljana was funded by the tobacco industry to dispute various measures in the tobacco law. This perpetual denial of the cause relationship of smoking and disease is the biggest misuse of science since the Nazi period but it also involuntarily contributed to the evolution of evidence based medicine.

About IBMI

Institute for Biostatistics and Medical Informatics (IBMI), formerly Institute for BioMedical Informatics (so still IBMI) was founded by the Faculty of Medicine as a result of a need for a unit which would perform, or coordinate, tasks related to data analysis and providing information, relevant for research in medicine. The programme of the institute, and its development, have been adjusting thorugh time to changes in financing and technological progress, but the basic aim remain the same: to support research in medicine. This is achieved through the following tasks:

Contact

Institute for Biostatistics and Medical Informatics
University of Ljubljana, Faculty of Medicine
Vrazov trg 2, 1000 Ljubljana
Slovenia

tel: +386 1 543-77-70
fax: +386 1 543-77-71
email: ibmi (at) mf.uni-lj.si